4: Statement of changes in beneficial ownership of securities-Officer Zannes Maria
4: Statement of changes in beneficial ownership of securities-Officer Zannes Timothy P
4: Statement of changes in beneficial ownership of securities-Director GIRGENTI STEVEN
424B3: Prospectus
EFFECT: Others
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | ARS: Annual Report to Security Holders
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | DEF 14A: Definitive information statements
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | DEFA14A: Others
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | EFFECT: Others
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | S-1: General form for registration of securities under the Securities Act of 1933
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | PRE 14A: Preliminary proxy statements relating to merger or acquisition
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 10-K: Annual report
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 8-K: bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Officer GIRGENTI STEVEN
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-Director Anderson Robert A.
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | D: Filing D
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 8-K: Current report
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 8-K: Current report
No Data